Your Patients Can't Find Asthmanefrin — Here's How You Can Help

When patients tell you they can't find their asthma medication, it's more than a logistical problem — it's a clinical concern. Asthmanefrin (Racepinephrine Hydrochloride 2.25%) is an over-the-counter bronchodilator that many patients rely on, and its inconsistent retail availability in 2026 means some of your patients may be going without rescue medication.

This guide provides a practical framework for helping patients navigate Asthmanefrin supply issues, evaluate alternatives, and ensure they have reliable access to asthma relief.

Current Asthmanefrin Availability

As of early 2026, Asthmanefrin is still in production by Nephron Pharmaceuticals but remains intermittently available at retail pharmacies. Key facts:

• Not on the FDA drug shortage list (OTC products often aren't tracked)
• Racepinephrine has appeared on the ASHP shortage list historically
• Available at Walmart, CVS, Walgreens, and Amazon — but stock varies widely
• Direct ordering available through asthmanefrin.com
• Pricing: Starter Kit $35-$50; 30-count Refill $30-$75+
• No generic OTC equivalent exists

For the latest supply details, see the provider shortage briefing.

Why Patients Can't Find It

Understanding the root causes helps you counsel patients effectively:

Single-Source Manufacturing

Nephron Pharmaceuticals is the only manufacturer. No generic OTC racepinephrine product exists, making the supply inherently fragile.

Limited Retail Shelf Space

As a niche OTC product, Asthmanefrin gets minimal shelf space at most retailers. A handful of purchases can empty the local supply, with restocking taking days to weeks.

OTC Products Outside Standard Pharmacy Workflows

Unlike prescription medications, OTC products like Asthmanefrin don't go through the pharmacy dispensing workflow. Patients can't call their pharmacist to check stock or place a refill — they have to physically look for it or search online.

Price Sensitivity

Patients report prices rising from ~$35 to $70+ for a 30-count refill. When prices spike, patients may delay purchases, creating a cycle of stockouts and panic buying.

What Providers Can Do: 5 Practical Steps

Step 1: Assess Whether OTC Asthmanefrin Is the Right Fit

Use the Asthmanefrin discussion as a clinical opportunity. Asthmanefrin is appropriate for mild, intermittent asthma only. Red flags that suggest the patient needs more:

• Using Asthmanefrin more than twice per week
• Nighttime symptoms more than twice per month
• Any interference with normal activities
• FEV1 below 80% predicted

If any of these apply, the patient likely has persistent asthma and would benefit from a controller medication (inhaled corticosteroid) plus a prescription rescue inhaler.

Step 2: Prescribe an Appropriate Alternative When Indicated

If the clinical assessment supports stepping up therapy, or if the patient simply can't reliably access Asthmanefrin, consider:

• Albuterol (ProAir, Ventolin, Proventil): Selective beta-2 agonist, better safety profile than racepinephrine. Generic inhalers $25-$50 without insurance; as low as $15-$25 with discount cards.
• Levalbuterol (Xopenex): R-isomer of Albuterol; may reduce tremor and tachycardia side effects. More expensive ($50-$100+).
• Combination approach: Albuterol for rescue plus low-dose ICS (Fluticasone, Budesonide) for maintenance if persistent symptoms are present.

Note that for children aged 4-11 who have been using Asthmanefrin, Albuterol nebulizer solution is an appropriate prescription alternative that uses a similar delivery method.

Step 3: Direct Patients to Reliable Sources

For patients who want to continue with Asthmanefrin, help them find it:

• Medfinder for Providers: Share this tool with patients. It helps locate hard-to-find medications at pharmacies near them.
• Asthmanefrin.com: Manufacturer direct ordering, often available when retail stores are not.
• Independent pharmacies: May have different supply chains from large chains and be able to special-order the product.

Step 4: Document the Patient's Plan

When a patient relies on an OTC product for rescue medication, document this in the medical record along with:

• Current asthma severity classification
• OTC medication being used and frequency
• Backup prescription written (if applicable)
• Patient education provided about when to seek emergency care

This creates a safety net if the patient can't access Asthmanefrin and needs to fill a prescription quickly.

Step 5: Provide a Backup Prescription

Consider writing a backup Albuterol prescription for any patient who uses Asthmanefrin as their primary rescue medication. Even if they don't fill it immediately, having a valid prescription on file means they can get Albuterol from any pharmacy if Asthmanefrin becomes unavailable.

Frame it to the patient: "I want you to have a backup plan in case you can't find Asthmanefrin. This prescription for Albuterol is your safety net."

Alternatives at a Glance

A quick reference for your conversations with patients:

• Primatene Mist (OTC): Epinephrine MDI, ages 12+, ~$25-$35, widely available. Closest OTC alternative.
• Albuterol (Rx): Beta-2 selective, ages 2+, $25-$50 generic, gold standard rescue therapy.
• Levalbuterol (Rx): R-isomer of Albuterol, may have fewer side effects, $50-$100+.
• Ipratropium (Rx): Anticholinergic, useful as add-on therapy, not a standalone rescue option.

For detailed clinical comparisons, see our alternatives to Asthmanefrin article.

Workflow Tips for Your Practice

Integrating these steps into your workflow doesn't have to be burdensome:

• Intake screening: Ask patients about OTC medication use during intake. Many patients won't mention OTC products unless asked directly.
• Pre-visit planning: If a chart shows OTC asthma medication use, flag it for discussion during the visit.
• After-visit summary: Include links to Medfinder and asthmanefrin.com in patient handouts or after-visit summaries.
• Staff education: Ensure your clinical staff understands the difference between OTC and prescription asthma products so they can triage patient calls effectively.

Final Thoughts

Asthmanefrin supply issues are a practical problem with a clinical opportunity embedded in them. Every patient who can't find Asthmanefrin is a patient who deserves a thorough asthma assessment, a conversation about optimal therapy, and a reliable backup plan.

By using tools like Medfinder for Providers, writing backup prescriptions, and counseling patients about their options, you can turn a supply chain frustration into better outcomes for your patients.

For the latest supply status and clinical considerations, see our Asthmanefrin shortage briefing for providers. For patient-facing resources, share our guide on how to find Asthmanefrin in stock.